Pharmalucence, Inc.
- UEI
- VFG7FHXXAMN3
- CAGE
- 0UB47
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- sunpharma.com
- Founded
- 1983
- Employees
- 10K-50K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $140,878 |
| FY2024 | $155,000 |
| FY2023 | $25,000 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Radiopharmaceticals and supples | Medical Command (Army) | $40,878 | |
| Various radiopharmacueticals | Medical Command (Army) | $100,000 | |
| Radiopharmaceticals and supples | Medical Command (Army) | $75,000 | |
| Various radiopharmacueticals | Medical Command (Army) | $80,000 | |
| Radiopharmaceticals and supples | Medical Command (Army) | $25,000 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Sun Pharmaceutical Industries, Inc. | Princeton, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Allens Nutech Inc. | Tyler, TX | 325412 Pharmaceutical Preparation Manufacturing |
| Lantheus Holdings, Inc. | Bedford, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Curium US LLC | Maryland Heights, MO | 325412 Pharmaceutical Preparation Manufacturing |
| Southeast Apothecary, Inc. | Montgomery, AL | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Pharmalucence, Inc. is a specialty pharmaceutical manufacturer registered in SAM.gov since 2001, specializing in the production and distribution of generic radiopharmaceutical products and supplies for medical diagnostic services. As a for-profit, corporate entity structured as a Subchapter S Corporation, the company primarily serves federal government agencies with critical medical supply contracts. The company focuses on providing radiopharmaceuticals that support nuclear medicine diagnostic services, particularly for military healthcare environments.
Pharmalucence, Inc. has been awarded multiple federal contracts by the Defense Health Agency (DHA), a component of the Department of Defense, for supplying radiopharmaceuticals and related medical supplies. These contracts, predominantly firm fixed-price blanket purchase agreement (BPA) call contracts, range in value from $25,000 to $100,000 and are designed to support nuclear medicine diagnostic services for military treatment facilities. The contract awards have consistently targeted the procurement of specialized radiopharmaceuticals used for imaging various medical conditions, including breast cancer nodules, liver malignancies, and gall bladder malignancies. Notably, most of these contracts have no specific set-aside designation, indicating open competition, and are aimed at supporting the Medical Health System's 9.5 million beneficiaries, including active duty personnel and their families.
Pharmalucence, Inc. holds two significant federal contract Indefinite Delivery Vehicles (IDVs): a $1.25 million BPA with the Department of the Army Medical Command for radiopharmaceutical supplies at Tripler Army Medical Center in Hawaii from May 2021 through April 2026, and a $1 million BPA to provide radiopharmaceuticals to various military treatment facilities from October 2020 through September 2025. These IDVs have enabled the Defense Health Agency to award multiple task orders, including contracts for facilities in Fort Sam Houston and El Paso, Texas. The IDVs are single-award contracts with no specific set-aside designation, demonstrating the company's capability to directly support military medical readiness through streamlined procurement of specialized pharmaceutical supplies.
Quick answers
Is Pharmalucence, Inc. registered in SAM.gov?
Pharmalucence, Inc.'s SAM.gov registration expired on November 4, 2022.
How much has Pharmalucence, Inc. received in federal contracts?
Federal contracts obligated $140,878 to Pharmalucence, Inc. in fiscal year 2025 and $320,878 in fiscal years 2023 through 2027.
What is Pharmalucence, Inc.'s most recent federal award?
Pharmalucence, Inc.'s most recent federal contract award is Radiopharmaceticals and supples (W81K0024F0147), from Medical Command (Army), on October 1, 2024.
On GovTribe
See Pharmalucence, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors